{"count": 1, "results": [{"_id": "21219847", "pmid": 21219847, "title": "Ambulatory blood pressure, endothelial perturbation, and microvascular complications in type 2 diabetes.", "journal": "Dan Med Bull", "authors": ["Knudsen ST"], "date": "2010-06-01T00:00:00Z", "meta_date_publication": "2010 Jun", "meta_volume": "57", "meta_issue": "6", "meta_pages": "B4145", "score": 50051.91, "text_hl": "Non-dipping and elevated PP were associated with increased plasma levels of markers of endothelial activation in T2DM @SPECIES_9606 @@@patients@@@, suggesting that endothelial perturbation could represent a pathophysiological link between these haemodynamic risk factors and the development of @DISEASE_Diabetic_Angiopathies @DISEASE_MESH:D003925 @@@vascular complications@@@ in T2DM. 4 months treatment with @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ 50 mg o.d. did not ameliorate @DISEASE_Macular_Edema @DISEASE_MESH:D008269 @@@macular oedema@@@ in T2DM @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Macular_Degeneration</m> @DISEASE_MESH:D008268 @@@maculopathy@@@. 12 months dual blockade of the @GENE_REN @GENE_5972 @@@renin@@@-angiotensin system with @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ reduced ambulatory PP levels compared with high-dose @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ monotherapy in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive T2DM@@@ subjects.", "citations": {"NLM": "Knudsen ST. Ambulatory blood pressure, endothelial perturbation, and microvascular complications in type 2 diabetes. Dan Med Bull. 2010 Jun;57(6):B4145. PMID: 21219847", "BibTeX": "@article{21219847, title={Ambulatory blood pressure, endothelial perturbation, and microvascular complications in type 2 diabetes.}, author={Knudsen ST}, journal={Dan Med Bull}, volume={57}, number={6}, pages={B4145}}"}}]}